AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Anti-fat drug tied to cancer risk
Vanderbilt University researchers said that the GlaxoSmithKline experimental compound GW501516, designed to fight obesity and lower cholesterol levels, was found to increase the risk of developing colon cancer. However, Vanderbilt's tests were done on mice prone to develop cancer, and the drug firm says it has observed no such a link.
** Birth-control pills, or patches, do not cause women to put on weight, U.S. and Dutch researchers have found, rejecting a commonly ...